A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents

To assess a patient empowerment program (PEP) for children/adolescents with primary immunodeficiency (PID) on IgG replacement therapy regarding quality of life (QoL) in patients and proxy. Health-related QoL was assessed using KIDSCREEN-27 and DISABKIDS-37 before and 6 months after PID-PEP kids in 1...

Full description

Saved in:
Bibliographic Details
Published inImmunotherapy Vol. 16; no. 12; p. 813
Main Authors Fasshauer, Maria, Schuermann, Gesine, Gebert, Norbert, Bernuth, Horst von, Bullinger, Monika, Goldacker, Sigune, Krueger, Renate, Manzey, Petra, Messner, Stefanie, Renner, Ellen D, Ritterbusch, Henrike, Schauer, Uwe, Schulze, Ilka, Umlauf, Volker, Widmann, Steffi, Baumann, Ulrich
Format Journal Article
LanguageEnglish
Published England 03.07.2024
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To assess a patient empowerment program (PEP) for children/adolescents with primary immunodeficiency (PID) on IgG replacement therapy regarding quality of life (QoL) in patients and proxy. Health-related QoL was assessed using KIDSCREEN-27 and DISABKIDS-37 before and 6 months after PID-PEP kids in 19 children/adolescents and their parents. The following three dimensions of the KIDSCREEN-27 significantly increased in children/adolescents after PID-PEP kids as compared with baseline: Psychological Well-Being, Parents & Autonomy and School Environment. Total DISABKIDS-37 index, as well as 5 of the 6 DISABKIDS-37 dimensions, significantly increased, in other words, Independence, Emotion, Social Inclusion, Social Exclusion and Physical. Evaluation of proxy instruments showed comparable results. PID-PEP kids significantly improved QoL in patients with PID.
ISSN:1750-7448
DOI:10.1080/1750743X.2024.2367924